# Dolby Laboratories, Inc.: overview

DLB · NYSE · CIK 1308547 · [Financials](/sectors/financials.md) · fiscal year ends Sep 27

Pages: [Overview](/companies/dlb.md) · [Financials](/companies/dlb/financials.md) · [Filings](/companies/dlb/filings.md) · [Insiders](/companies/dlb/insiders.md)

Latest reported revenue: [$305.0m](/filings/0001308547-26-000013.md) for Q3 FY2026, three months to 2026-06-26, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001308547-26-000013).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-09-26) | Q1 FY2026 (2025-12-26) | Q2 FY2026 (2026-03-27) | Q3 FY2026 (2026-06-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [305 d](/filings/0001308547-25-000007.md) | [357](/filings/0001308547-26-000005.md) | [370](/filings/0001308547-26-000010.md) | [316](/filings/0001308547-26-000013.md) | [307 d](/filings/0001308547-25-000007.md) | [347](/filings/0001308547-26-000005.md) | [396](/filings/0001308547-26-000010.md) | [305](/filings/0001308547-26-000013.md) |
| Gross margin | % | [88.8% d](/filings/0001308547-25-000007.md) | [88.6%](/filings/0001308547-26-000005.md) | [90.3%](/filings/0001308547-26-000010.md) | [86.1%](/filings/0001308547-26-000013.md) | [87.1% d](/filings/0001308547-25-000007.md) | [87.5%](/filings/0001308547-26-000005.md) | [88.7%](/filings/0001308547-26-000010.md) | [86.8%](/filings/0001308547-26-000013.md) |
| Operating margin | % | [15.2% d](/filings/0001308547-25-000007.md) | [22.4%](/filings/0001308547-26-000005.md) | [29.2%](/filings/0001308547-26-000010.md) | [15.1%](/filings/0001308547-26-000013.md) | [9.7% d](/filings/0001308547-25-000007.md) | [17.9%](/filings/0001308547-26-000005.md) | [28.5%](/filings/0001308547-26-000010.md) | [11.3%](/filings/0001308547-26-000013.md) |
| Net margin | % | [19.2% d](/filings/0001308547-25-000007.md) | [19.0%](/filings/0001308547-26-000005.md) | [24.8%](/filings/0001308547-26-000010.md) | [14.6%](/filings/0001308547-26-000013.md) | [16.1% d](/filings/0001308547-25-000007.md) | [15.4%](/filings/0001308547-26-000005.md) | [24.0%](/filings/0001308547-26-000010.md) | [9.4%](/filings/0001308547-26-000013.md) |
| Diluted EPS | $ per share | not reported | [0.70](/filings/0001308547-26-000005.md) | [0.94](/filings/0001308547-26-000010.md) | [0.48](/filings/0001308547-26-000013.md) | not reported | [0.55](/filings/0001308547-26-000005.md) | [0.99](/filings/0001308547-26-000010.md) | [0.30](/filings/0001308547-26-000013.md) |
| Free cash flow | $m | [109 d](/filings/0001308547-25-000007.md) | [100](/filings/0001308547-26-000005.md) | [168 d](/filings/0001308547-26-000010.md) | [61.3 d](/filings/0001308547-26-000013.md) | [107 d](/filings/0001308547-25-000007.md) | [50.2](/filings/0001308547-26-000005.md) | [83.4 d](/filings/0001308547-26-000010.md) | [152 d](/filings/0001308547-26-000013.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-24) | FY2022 (2022-09-30) | FY2023 (2023-09-29) | FY2024 (2024-09-27) | FY2025 (2025-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,281](/filings/0001628280-23-039389.md) | [1,254](/filings/0001628280-24-048519.md) | [1,300](/filings/0001308547-25-000007.md) | [1,274](/filings/0001308547-25-000007.md) | [1,349](/filings/0001308547-25-000007.md) |
| Gross margin | % | [89.9%](/filings/0001628280-23-039389.md) | [88.7%](/filings/0001628280-24-048519.md) | [88.3%](/filings/0001308547-25-000007.md) | [89.0%](/filings/0001308547-25-000007.md) | [88.1%](/filings/0001308547-25-000007.md) |
| Operating margin | % | [26.9%](/filings/0001628280-23-039389.md) | [16.5%](/filings/0001628280-24-048519.md) | [16.6%](/filings/0001308547-25-000007.md) | [20.3%](/filings/0001308547-25-000007.md) | [19.6%](/filings/0001308547-25-000007.md) |
| Net margin | % | [24.2%](/filings/0001628280-23-039389.md) | [14.7%](/filings/0001628280-24-048519.md) | [15.4%](/filings/0001308547-25-000007.md) | [20.6%](/filings/0001308547-25-000007.md) | [18.9%](/filings/0001308547-25-000007.md) |
| Diluted EPS | $ per share | [2.97](/filings/0001628280-23-039389.md) | [1.81](/filings/0001628280-24-048519.md) | [2.05](/filings/0001308547-25-000007.md) | [2.69](/filings/0001308547-25-000007.md) | [2.62](/filings/0001308547-25-000007.md) |
| Free cash flow | $m | [393](/filings/0001628280-23-039389.md) | [271](/filings/0001628280-24-048519.md) | [337](/filings/0001308547-25-000007.md) | [297](/filings/0001308547-25-000007.md) | [436](/filings/0001308547-25-000007.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dlb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $351.1m | 6,676,885 |  | Added +138,549 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $260.3m | 4,950,702 |  | Reduced −20,122 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $253.3m | 4,817,216 |  | Added +317,396 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $242.0m | 4,601,750 |  | Reduced −540,418 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $143.1m | 2,721,876 |  | Reduced −4,499 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $142.3m | 2,705,504 |  | Added +450,571 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $121.8m | 2,317,402 |  | Added +26,823 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $96.9m | 1,842,203 |  | Added +77,094 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $83.4m | 1,585,579 |  | Added +573,059 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $81.9m | 1,558,169 |  | Added +236,762 |

## Recent filings

[All 1,846 filings](/companies/dlb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-27 | 09:00 ET | [8-K](/filings/0001193125-26-369707.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-369707 |
| 2026-07-30 | 16:37 ET | [10-Q](/filings/0001308547-26-000013.md) | Quarterly report, period 2026-06-26 | 0001308547-26-000013 |
| 2026-07-30 | 16:15 ET | [8-K](/filings/0001193125-26-326149.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326149 |
| 2026-04-30 | 16:45 ET | [10-Q](/filings/0001308547-26-000010.md) | Quarterly report, period 2026-03-27 | 0001308547-26-000010 |
| 2026-04-30 | 16:15 ET | [8-K](/filings/0001193125-26-197338.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197338 |
| 2026-02-13 | 17:33 ET | [SCHEDULE 13D/A](/filings/0001193125-26-051828.md) | Ownership report, active investor, amended | 0001193125-26-051828 |
| 2026-02-06 | 16:15 ET | [8-K](/filings/0001193125-26-041211.md) | 5.07 Shareholder vote results | 0001193125-26-041211 |
| 2026-01-29 | 16:57 ET | [10-Q](/filings/0001308547-26-000005.md) | Quarterly report, period 2025-12-26 | 0001308547-26-000005 |
| 2026-01-29 | 16:15 ET | [8-K](/filings/0001193125-26-029373.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029373 |
| 2025-12-16 | 08:30 ET | [DEF 14A](/filings/0001193125-25-320032.md) | Proxy statement, period 2026-02-03 | 0001193125-25-320032 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 26, 2025](/filings/0001308547-25-000007.md), filed Nov 18, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-26, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/07ff0ce7-5b73-410f-8e09-c86a7d9d3c8a)

## About the filer

- CIK: 1308547
- Tickers: DLB
- Exchange: NYSE
- SIC code: 6794 Patent Owners & Lessors
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:52 ET. No prices; not investment advice.